Lori L Davis MD

Psychiatry•Tuscaloosa, AL

Physician

Join to View Full Profile

3701 Loop RdTuscaloosa Va Medical CenterTuscaloosa, AL 35404
Phone+1 205-554-2000
Fax+1 205-554-2877

Education & Training

University of Alabama Medical CenterResidency, Psychiatry, 1988 - 1992
University of North Carolina at Chapel Hill School of MedicineClass of 1988

Certifications & Licensure

AL State Medical License 1989 - 2025
NC State Medical License 1989 - 2025
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder Start of enrollment: 2003 May 01
Terminated
Phase 4
Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial Start of enrollment: 2003 May 01
Completed
Phase 4
Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD) Start of enrollment: 2001 Jul 01
Completed
Phase 4
Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder Start of enrollment: 2004 Jan 01
Completed
Phase 4
Carbamazepine Extended-Release for the Treatment of Bipolar Depression Start of enrollment: 2005 Aug 01
Completed
Phase 4
A Placebo-Controlled Study of Mirtazapine for PTSD in OIF/OEF Veterans and Veterans From All Other Southwest Asia Conditions Start of enrollment: 2006 Oct 01
Divalproex vs. Lamotrigine for Bipolar Disorder Start of enrollment: 2006 Feb 01
Terminated
Characterization of Recently Deployed Veterans Start of enrollment: 2005 Feb 01
Completed
Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans Start of enrollment: 2009 Jul 01
Completed
Phase 2
Alabama Veterans Rural Health Initiative Start of enrollment: 2008 Oct 01
Completed
Not Applicable
Veterans Individual Placement and Support Towards Advancing Recovery Start of enrollment: 2013 Dec 31
Completed
Not Applicable
Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD Start of enrollment: 2019 May 20
Terminated
Phase 2
Minds and Mentors Program- R33 Start of enrollment: 2022 Jan 04
Recruiting
Not Applicable
Roles: Contact
Together in Recovery With Veterans Through Employment Start of enrollment: 2022 Dec 16
RECRUITING
NA
Roles: Contact
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder Start of enrollment: 2020 Nov 03
RECRUITING
PHASE4
Roles: Contact
VA Aripiprazole vs Esketamine for Treatment Resistant Depression Start of enrollment: 2023 Oct 27
Withdrawn
Phase 4
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

1 citations
Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder: A Phase 3 Randomized Clinical Trial.
Lori L Davis, Saloni Behl, Daniel Lee, Hui Zeng, Taisa Skubiak
JAMA Psychiatry. 2025-03-01
1 citations
Brexpiprazole in Combination With Sertraline and as Monotherapy in Posttraumatic Stress Disorder: A Full-Factorial Randomized Clinical Trial.
Mary Hobart, Denise Chang, Nanco Hefting, Lori L Davis
The Journal of Clinical Psychiatry. 2025-02-19
Study protocol and preliminary baseline characteristics of a VA multi-site, mixed methods, randomized controlled study evaluating supported employment provided to vete...
Mercy Mumba, Teresa Granger, George Mugoya, Stephen Brackett, Junfei Lu
Annals of General Psychiatry. 2024-12-18

Press Mentions

JAMA Psychiatry Publishes Results of Otsuka and Lundbeck's Phase 3 Trial of Brexpiprazole in Combination with Sertraline in Treatment of Post-Traumatic Stress Disorder (PTSD) in AdultsDecember 18th, 2024
MDMA Is off the Table, so What’s Next for PTSD?October 17th, 2024